ConductScience.org, home

Paper20175034

Current strategy for staging and treatment: the BCLC update and future prospects.

Forner A and 3 others. Semin Liver Dis, 2010. Cited by 891 papers, by iCite.

Cite this record

ConductScience Library. Current strategy for staging and treatment: the BCLC update and future prospects. Papers, record 20175034. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20175034

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Current strategy for staging and treatment: the BCLC update and future prospects.
PubMed
Journal
Semin Liver Dis
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
891
iCite
Relative citation ratio, by iCite
27
iCite
Revised in PubMed
2026-01-28
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Forner AAlejandro
2Reig MEMaría E
3de Lope CRCarlos Rodriguez
4Bruix JJordi

Source PubMed

Download CSV of authors

Topics24

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
Neoplasm InvasivenessMajor topic
Neoplasm StagingMajor topic
Antineoplastic Agents
Benzenesulfonates
Clinical Trials, Phase III as Topic
Drug Delivery Systems
Female
Forecasting
Hepatectomy
Humans
Liver Transplantation
Male
Niacinamide
Phenylurea Compounds
Prognosis
Pyridines
Randomized Controlled Trials as Topic
Risk Assessment
Sorafenib
Spain
Survival Analysis
Treatment Outcome

Source PubMed

Download CSV of topics

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT03322280TACE Combined With Iodine-125 Seeds Implantation for HCCBackgroundClinicalTrials.gov
NCT07657897The Impact of Anaesthesia and Sedation on Inflammation and NETosis in Hepatocellular Carcinoma AblationResultsClinicalTrials.gov

Download CSV of trials

Cited by521

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 891 citations.

PMIDTitleJournalYearIn PapersSource
42583674Decoding the Complexity of Hepatocellular Carcinoma: Clinical Challenges and Targeting HuR as a Novel Therapeutic Strategy.Livers2026https://conductscience.org/library/papers/42583674PubMed
42342274Trends in the incidence and surgical treatment of hepatocellular carcinoma in Ontario.Can J Surg2026https://conductscience.org/library/papers/42342274PubMed
42329540Advances in oncolytic viruses immunotherapy of hepatocellular carcinoma.Discov Oncol2026https://conductscience.org/library/papers/42329540PubMed
42111212A BCLC-based prognostic nomogram for hepatocellular carcinoma: Development and validation.iScience2026https://conductscience.org/library/papers/42111212PubMed
41976373Modified Charlson Comorbidity Index to Improve Management of Patients with Hepatocellular Carcinoma: A Step Towards Multiparametric Approach.Cancers (Basel)2026https://conductscience.org/library/papers/41976373PubMed
41602406Application of propensity score matching in prognostic analysis of portal hypertension in hepatocellular carcinoma patients.Front Oncol2025https://conductscience.org/library/papers/41602406PubMed
41374333Quantitative CT Perfusion and Radiomics Reveal Complementary Markers of Treatment Response in HCC Patients Undergoing TACE.Diagnostics (Basel)2025https://conductscience.org/library/papers/41374333PubMed
41166641Clinical management of liver cancer patients with immune checkpoint inhibitors treatment.Hepat Oncol2025https://conductscience.org/library/papers/41166641PubMed
41143168P-ART Score is a New Modification to Improve ART Score Predictive Accuracy for Patients with HCC Undergoing TACE.J Hepatocell Carcinoma2025https://conductscience.org/library/papers/41143168PubMed
41107444The efficacy and safety analysis of D-TACE combined with donafenib and tislelizumab in recurrent hepatocellular carcinoma after surgery.Sci Rep2025https://conductscience.org/library/papers/41107444PubMed
41024880Re-evaluating surgical strategies in Barcelona Clinic Liver Cancer-B hepatocellular carcinoma.World J Hepatol2025https://conductscience.org/library/papers/41024880PubMed
41018076A comparative study of postural fixation techniques for radiotherapy in upper abdominal malignancies.Front Oncol2025https://conductscience.org/library/papers/41018076PubMed
40904655Interplay of PNPLA3 and TM6SF2 variants in modulating the risk of hepatocellular carcinoma among Egyptian hepatitis C patients.Clin Exp Hepatol2025https://conductscience.org/library/papers/40904655PubMed
40790551Efficacy of prophylactic dexamethasone in reducing post-embolization syndrome following transcatheter arterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis.BMC Gastroenterol2025https://conductscience.org/library/papers/40790551PubMed
40636794Multi-feature weight factor extraction and survival risk assessment of hepatocellular carcinoma based on a clinical missing dataset-independent support vector machine.ILIVER2022https://conductscience.org/library/papers/40636794PubMed
40512454Stereotactic body radiation therapy (SBRT) increases anti-PD-1 antitumor activity by enhancing the tumor immune microenvironment in mice with metastatic hepatocellular carcinoma.Discov Oncol2025https://conductscience.org/library/papers/40512454PubMed
40380811Liver transplantation as a treatment for cancer: comprehensive review.BJS Open2025https://conductscience.org/library/papers/40380811PubMed
40380115RALOX-HAIC (raltitrexed + oxaliplatin) combined with lenvatinib improves survival and safety in elderly patients with unresectable hepatocellular carcinoma.BMC Cancer2025https://conductscience.org/library/papers/40380115PubMed
40361344Extrahepatic Recurrence After Surgical Resection of Hepatocellular Carcinoma Without Intrahepatic Recurrence: A Multi-Institutional Observational Study.Cancers (Basel)2025https://conductscience.org/library/papers/40361344PubMed
40361115Preoperative plasma cell-free DNA chromosomal instability predicts microvascular invasion in hepatocellular carcinoma: a prospective study.BMC Cancer2025https://conductscience.org/library/papers/40361115PubMed

See all 521 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20175034

GET https://conductscience.org/api/papers/v1/20175034/cited_by?page=2